Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 616.50
Bid: 617.50
Ask: 618.50
Change: -6.50 (-1.04%)
Spread: 1.00 (0.162%)
Open: 625.00
High: 627.00
Low: 614.00
Prev. Close: 623.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ITC Case Update

23 Sep 2008 07:00

Tate & Lyle PLC ITC patent infringement case: update Tate & Lyle PLC ("Tate & Lyle") announces that on 22 September 2008 anAdministrative Law Judge at the U.S. International Trade Commission ("ITC") inWashington D.C. gave his initial/preliminary ruling in respect of thepatent-infringement case against certain manufacturers and importers of Chinesesucralose. With the exception of certain non-participating and defaultedDefendants, the Judge did not agree with Tate & Lyle's claims. The Judge'sinitial determination concerning the infringement ruling follows the trialearlier this year. A binding final determination by the full six-personCommission is expected by January 2009. Robert Gibber, General Counsel of Tate & Lyle, said "This is a complex caseinvolving a huge amount of in-depth technical analysis and debate betweenscientific experts. We would not have proceeded with an ITC case unless webelieved we had adequate evidence to demonstrate that our patents are beinginfringed. We intend to petition for an appeal of the decision by the fullCommission." Karl Kramer, President, Tate & Lyle Sucralose said, "Intellectual property isjust one of a number of different layers of protection which define Tate &Lyle's formidable competitive advantage in the global sucralose business. Ourfacilities in the US and Singapore, which operate at a level of cost, efficiencyand environmental stewardship surpassed by none, produce sucralose which meetsthe highest standards of quality, purity and hygiene. Our business is built uponlong-standing relationships with some of the world's leading food, beverage andpharmaceutical manufacturers, as well as the established SPLENDA(R) brand whichis renowned as a high quality, reliable and trusted product in a number ofmarkets." END For more information contact Tate & Lyle PLC: Tim Lodge, Acting Group Finance Director and Director of Investor Relations Tel: 020 7626 6525 or Mobile: 07798 837317 Rowan Adams, Director of Corporate Affairs (Media) Tel: 020 7626 6525 or Mobile: 07713 067542 About Tate & Lyle: Tate & Lyle is a world-leading renewable food and industrial ingredientscompany, serving a global market from over 50 production facilities throughoutthe Americas, Europe and South East Asia. Our efficient, large-scalemanufacturing plants turn agricultural products, corn and cane sugar, intovaluable ingredients for our customers. These ingredients add taste, texture,nutrition and increased functionality to products that millions of people aroundthe world use or consume every day. Tate & Lyle's range of leading branded food ingredients includes SPLENDA(R)Sucralose, PROMITOR(TM) Dietary Fiber, STA-LITE(R) Polydextrose, Tate & LyleFairtrade Sugar and Lyle's Golden Syrup. Tate & Lyle also produces brandedindustrial ingredients including Bio-PDO(TM), Ethylex(R) and STA-Lock(R) paperstarches; and staple ingredients such as high fructose corn syrup, sugar,ethanol, citric acid and basic starches. In addition to providing a wide rangeof ingredients our expert sales and product applications teams support customersby providing technical advice and proprietary consumer insight studies. Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L.American Depositary Receipts trade under TATYY. In the year to 31 March 2008,Tate & Lyle employed 6,488 people in its subsidiaries and joint ventures, andsales totalled £3.4 billion. http://www.tateandlyle.com. SPLENDA(R) is atrademark of McNeil Nutritionals, LLC Copyright Business Wire 2008
Date   Source Headline
26th Jun 20245:38 pmRNSTransaction in Own Shares
25th Jun 20245:50 pmRNSTransaction in Own Shares
24th Jun 20245:35 pmRNSTransaction in Own Shares
24th Jun 20243:30 pmRNSHolding(s) in Company
21st Jun 20245:45 pmRNSTransaction in Own Shares
21st Jun 20242:45 pmRNSUpdate to the Notice of AGM 2024
20th Jun 20246:03 pmRNSTransaction in Own Shares
20th Jun 20247:05 amRNSLaunch of Share Buyback
20th Jun 20247:00 amRNSCombination of Tate & Lyle and CP Kelco
4th Jun 20245:22 pmRNSAnnual Financial Report and Notice of AGM
4th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 202412:00 pmRNSTotal Voting Rights
30th May 202412:15 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSFinal Results
23rd May 20247:00 amRNSSale of remaining interest in Primient JV to KPS
20th May 20241:00 pmRNSDirectorate Change
17th May 20243:30 pmRNSHolding(s) in Company
14th May 20243:30 pmRNSHolding(s) in Company
13th May 202410:00 amRNSHolding(s) in Company
8th May 20243:15 pmRNSHolding(s) in Company
1st May 20242:30 pmRNSTotal Voting Rights
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company
20th Mar 202412:00 pmRNSHolding(s) in Company
19th Mar 20242:00 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
12th Mar 20244:24 pmRNSHolding(s) in Company
12th Mar 20244:22 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSDirectorate Change
4th Mar 20242:00 pmRNSDirector/PDMR Shareholding
4th Mar 20241:45 pmRNSHolding(s) in Company
28th Feb 20242:30 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.